The US Food and Drug Administration (FDA) has approved tramadol hydrochloride (QDOLO Oral Solution) for the management of severe pain in adults.
The approval, granted to Athena Bioscience, is indicated specifically for patients who have not tolerated, or are not expected to tolerate, alternative treatment options. The opioid agonist is also limited to those for whom alternative treatments have not provided adequate analgesia.
The indication comes with a caution for patients to use a calibrated oral syringe or other dosing devices with metric measurements so as to ensure proper dosing amounts provided by a physician.Â
Read more here : https://www.hcplive.com/view/fda-approves-new-oral-solution-severe-pain-management
Comments